Patients With Rare Diseases And Congress Square Off Over Orphan Drug Tax Credits
The House and Senate want to reduce or eliminate federal tax credits for “orphan drugs†used to treat rare diseases, but patients are fighting against the plan.
The independent source for health policy research, polling, and news.
1,801 - 1,820 of 1,840 Results
The House and Senate want to reduce or eliminate federal tax credits for “orphan drugs†used to treat rare diseases, but patients are fighting against the plan.
The price for Pfizer’s Prevnar 13 has increased 5 to 6 percent each year since its 2010 approval by the Food and Drug Administration.
Drugmakers, hospitals and lawmakers are taking sides in a showdown over a discount program that covers drug purchases at some hospitals.
Even though the federal health law allows young adults to stay on their parents’ plan, those children are generally responsible for their own debts.
In this episode of “What the Health?†Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Alice Ollstein of Talking Points Memo and Sarah Jane Tribble of Kaiser Health News discuss some of the under-covered health stories of the past several weeks, including drug price issues, the opioid epidemic and women’s reproductive health.
The federal agents warned store owners that importing drugs from foreign countries is illegal and that those helping “administer†such medicines could face penalties.
Julie Rovner of Kaiser Health News, Sarah Kliff of Vox.com, Joanne Kenen of Politico and Alice Ollstein of Talking Points Memo discuss the inclusion of health policies into the current tax cut debate, including a possible repeal of the fines for people who fail to maintain health insurance.
Most states have laws that require that cancer patients who get their treatment orally rather than by infusion in a doctor’s office not pay more out-of-pocket. A new study finds that the impact of those laws is mixed.
Millions of dollars in campaign spending and a media blitz of advertisements muddy public understanding of Issue 2, the Drug Price Relief Act.
UnitedHealth, a health industry goliath, has its hand in doctors’ offices, surgery centers, technology services and prescription drugs. It is the industry model, and CVS and Aetna, says one expert, are ‘wannabes.’
About 9 million people claimed about $87 billion in medical deductions in 2015.
In this episode of “What the Health?†Julie Rovner of Kaiser Health News, Stephanie Armour of The Wall Street Journal, Joanne Kenen of Politico and Paige Winfield Cunningham of The Washington Post discuss the start of open enrollment under the Affordable Care Act, legislative efforts on Capitol Hill on taxes and children’s health insurance, and recommendations of the president’s opioid commission.
A quick guide to revisions to the cost-sharing subsidies for lower-income marketplace customers and the proposal to add different plans to the market.
Nearly three-quarters of Americans would like to see the administration focus on efforts on making the Affordable Care Act work, rather than trying to make it fail.
For several million consumers who buy their own insurance but earn too much to qualify for subsidies, the ever-growing price of premiums takes a big toll.
Tom Price resigned from running the Department of Health and Human Services after a series of news stories detailing how he tallied more than $400,000 in private plane travel paid for by taxpayers.Â
Those relying on the federal government’s safety net are grandmothers, the kid next door, your supermarket cashier — maybe even you.
Employers report the sixth consecutive year of small increases, but workers at small firms feel the biggest pinch, according to the Kaiser Family Foundation survey.
Not only are health prices hidden, industry players are contractually obligated to keep them secret. That’s why answering a simple question — how much does it cost to have a baby in Mountain View, Calif.? — became a journalistic quest.
This immunization may mark a shift among some vaccine makers to higher-priced, “niche†preventives that protect against very specific and sometimes rare illnesses.
© 2026 Â鶹ŮÓÅ